APAC CRO MARKET
Get instant access to latest e-book

latest newsRead more...

17

Dec 2018

Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China

Innovent Biologics Inc and Incyte today announced that the companies through their respective subsidiaries have entered into a strategic collaboration agreement for three clinicalstage product candidates discovered and developed by Incytepemigatinib FGFR inhibitor itacitinib JAK inhibitor and parsaclisib PIK inhibitor Under the terms of the…

15

Dec 2018

Astellas Acquires Potenza Therapeutics

Astellas Pharma Inc today announced that it exercised and closed on its exclusive option to acquire Potenza Therapeutics Inc Potenza on December US Eastern Time This acquisition marks the successful outcome of a collaboration agreement entered into in to build a portfolio of novel immunooncology…

14

Dec 2018

AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals

AMAG Pharmaceuticals Inc today announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc a private biopharmaceutical company Through this acquisition AMAG will acquire global rights to ciraparantag a next generation anticoagulant reversal agent further enhancing its development pipeline and leveraging AMAGs…

13

Dec 2018

Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration

XChem Inc a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics announced today a drug discovery partnership with Almirall SA Almirall to discover lead compounds for innovative and challenging targets with dermatology applications Under the…

13

Dec 2018

Lilly and AC Immune Announce License and Collaboration Agreement

Eli Lilly and Company and AC Immune SA today announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimers disease AD and other neurodegenerative diseases The collaboration combines…

press releasesRead more...

17

Dec 2018

Bridge Biotherapeutics Announces FDA Clearance of IND for its BBT-877, an Autotaxin Inhibitor for IPF

Bridge Biotherapeutics Inc a clinical stage biotech company headquartered in Seongnam South Korea and a tenant company of JLABSTMC in Houston Texas announced that the Investigational New Drug IND application…

16

Dec 2018

Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China

SUZHOU China Dec PRNewswire Innovent Biologics Inc Innovent HKEX and Incyte NASDAQINCY today announced that the companies through their respective subsidiaries have entered into a strategic collaboration agreement for three…

15

Dec 2018

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency

Orchard Therapeutics a leading commercialstage biopharmaceutical company dedicated to transforming the lives of patients with serious and lifethreatening rare diseases through innovative gene therapies and SIRION Biotech GmbH today announced…

14

Dec 2018

Recognize Mental Health as First Public Health Challenge, Says Dr. Prakriti Poddar, at Launch of Poddar Wellness Ltd

Business Wire IndiaDr Prakriti Poddar Director Poddar Wellness Ltd and Dr Indu Bhushan CEO Ayushman Bharat during Lamp Lighting Mental health leader Dr Prakriti Poddar launched Poddar Wellness Ltd in…

14

Dec 2018

With 72 Percent Employee Rating, Automobiles Is the Most Loved Sector to Work For: JobBuzz Workplace Index OND 2018 Report

Business Wire IndiaAutomobiles is one of the most preferred sectors for employment and for good reasons JobBuzz Workplace Index which tabulates the employee sentiments as comparable percentages revealed that most…

EventsRead more...

06-09

Jan 2019

12-14

Jan 2019

ICPSB 2019

International Journal of Pharma Medicine and Biological Sciences
Bella Vista Waterfront Langkawi

16-17

Jan 2019

Pre-Filled Syringes & Injectable Drug Devices

SMi Group Ltd
Copthorne Tara Hotel

16-18

Jan 2019

TOP ARTICLES

  • 4

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
  • 6

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..

Knowledge Bank

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia
    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..

  • Articles

    MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

    Introduction MicroRNAs is a noncoded double stranded RNAs made of approximately of nucleotides disclosed in by Ambros and Ruvkun laboratories that has significant role in regulation of gene expression at post transcriptional level It has been identified that the noncoding region of mRNA is capable of providing targeting signals in RNA binding protein domain…

  • Techno Trends

    NRX 100 Helps to Treat Severe Bipolar Depression with Acute Suicidal Ideation & Behavior (ASIB)

    NeuroRxs NRX the first oral drug targeting suicidal bipolar depression helps to treat severe bipolar depression with Acute Suicidal Ideation Behavior ASIB NRX is used for treatment of Severe Bipolar Depression with Acute Suicidal Ideation Behaviour after initial stabilisation with ketamine or other effective therapy NRX Dcycloserinelurasidone fixed dose combination is the first oral drug demonstrated in human volunteers to…

Editorial Section

  • Strategy

    Statin Drug Interactions and Related Adverse Reactions

    Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…

  • Research development

    Stem Cell and Gene Delivery

    These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…

  • Clinical Trials

    Managing Clinical Trial Agreements

    Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…

  • Information Technology

    R&D DATA HUB

    Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…

TOP